telehealth and opioid use disorder

When access to buprenorphine treatment became available to Medicaid beneficiaries in response to the COVID-19 crisis, patients who obtained such treatment via telehealth were more likely to remain under treatment for their disorder than those who received similar care through physician offices. This new finding, reported in the JAMA Network, suggests that prescribing buprenorphine treatment through telehealth may be beneficial to patients and should remain an option for patients and providers after the COVID-19-inspired policy, extended after the formal end of the public health emergency, expires at the end of 2024, as currently scheduled. While the study found that patients [...]